S&P 500
7,480.60
+0.41%
Dow Jones
52,044.90
+0.24%
Nasdaq 100
28,893.50
+0.93%
Russell 2000
2,957.47
+0.49%
FTSE 100
10,474.00
+0.10%
Nikkei 225
66,026.20
+1.42%

Personal Finance

GLUE logo Monte Rosa Therapeutics : GLUE

GLUE

Stock Data

$23.48

Change down

$1.08 (4.40%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Monte Rosa Therapeutics Inc is a pioneering biotechnology firm based in Boston, Massachusetts, focused on creating innovative medicines for cancer and other serious diseases. By harnessing the body's natural processes, it designs small molecule drugs that can precisely eliminate harmful proteins. Its leading projects target a range of conditions, including cancers driven by specific genetic factors, ovarian, uterine, and breast cancers, as well as inflammatory, neurodegenerative, diabetes, liver, and autoimmune diseases. Founded in 2019, Monte Rosa is at the forefront of developing treatments that aim to improve the lives of patients worldwide.

All Monte Rosa Therapeutics Articles

0 Articles

No articles found for Monte Rosa Therapeutics.